Ossur hf
CSE:OSSR
Ossur hf
Accounts Payable
Ossur hf
Accounts Payable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
O
|
Ossur hf
CSE:OSSR
|
Accounts Payable
$31.2m
|
CAGR 3-Years
7%
|
CAGR 5-Years
4%
|
CAGR 10-Years
3%
|
|
|
Embla Medical hf
CSE:EMBLA
|
Accounts Payable
$34.8m
|
CAGR 3-Years
7%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
Ossur hf
Glance View
Össur hf. is an Icelandic company that stands as a quiet marvel in the realm of orthopedic innovation, specializing in the development of non-invasive equipment designed to enhance human mobility. Born out of a small prosthetics shop in Reykjavik in 1971, the company has grown into a global leader in orthopedic solutions. At its core, Össur's operations revolve around the invention and commercialization of cutting-edge prosthetics, braces, and supports aimed at improving the quality of life for people who face limb challenges due to injuries, disabilities, or age-related conditions. The company's ethos of "Life Without Limitations" guides its pursuit to blend medical technology and engineering in a way that restores human dignity and functionality, manifesting a unique synergy between advanced robotics and biology. Commercially, Össur thrives by leveraging its commitment to research and development, channeling substantial investment into creating high-demand products characterized by reliability, adaptability, and innovation. Revenue streams primarily flow from the sale of prosthetic limbs and associated components, together with orthopedic support products that are distributed both directly and through a network of wholesalers and medical professionals worldwide. By maintaining a diversified product line and focusing on customer-centric customization, Össur meets a significant demand within healthcare systems, insurance providers, and direct consumer markets. The company's ability to translate its scientific prowess into marketable and life-enhancing solutions has cemented its reputation as a key player in the med-tech industry, aligning financial success with a meaningful social mission.
See Also
What is Ossur hf's Accounts Payable?
Accounts Payable
31.2m
USD
Based on the financial report for Mar 31, 2024, Ossur hf's Accounts Payable amounts to 31.2m USD.
What is Ossur hf's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
3%
Over the last year, the Accounts Payable growth was 9%. The average annual Accounts Payable growth rates for Ossur hf have been 7% over the past three years , 4% over the past five years , and 3% over the past ten years .
You don't have any saved screeners yet